FDA Clears First Human Epigenetic Reprogramming Trial in U.S. — What the Harvard-Backed Anti-Aging Therapy Could Mean for You

Harvard-backed Life Biosciences has received FDA clearance for the first-ever human epigenetic reprogramming trial. Here's what it targets and why it matters.

This story was reported by Medical Daily. EUROPES curates Europe's most relevant coverage — read the full report at the original source.